KRAS and pachyonychia congenita: To investigate the potential interaction between KRAS and PPAR signaling in PC, we evaluated the effect on cell viability in KRAS p.G12C and KRAS p.G12D mutated PC cell lines treated in vitro with the KRAS inhibitor Sotorasib alone or combined with the PPAR inhibitor GW9662.